China Pharma Univ. GPX4 compound W25

China Pharma Univ. GPX4 compound W25: sourced facts only. name: "These results suggest that W25 is a novel ferroptosis inducer against colorectal cancer through the inhibition of GPX4." [PMID:40982994]; target: "These results suggest that W25 is a novel ferroptosis inducer against colorectal cancer through the inhibition of GPX4." [PMID:40982994]; developer: "State Key Laboratory of Natural Medicines, Basic Medical Research Innovation Center for Anti-Cancer Drugs, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, People's Republic of China." [PMID:40982994]; stage: "Remarkably, compound W25 displayed the most potent antitumor efficacy against HCT-116 colorectal cancer cells, surpassing the activity of the parent compound arctigenin." [PMID:40982994]